1. Executive Summary
1.1. Global Digital Therapeutics Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2022
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Digital Therapeutics Market Outlook, 2018 - 2030
3.1. Global Digital Therapeutics Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
3.1.1. Key Highlights
3.1.1.1. Diabetes
3.1.1.2. Obesity
3.1.1.3. CVD
3.1.1.4. Smoking Cessation
3.1.1.5. CNS Diseases
3.1.1.6. Others
3.2. Global Digital Therapeutics Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
3.2.1. Key Highlights
3.2.1.1. Patients
3.2.1.2. Providers
3.2.1.3. Payers
3.2.1.4. Employers
3.2.1.5. Other End users
3.3. Global Digital Therapeutics Market Outlook, by Region, Value (US$ Bn), 2018 - 2030
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America Digital Therapeutics Market Outlook, 2018 - 2030
4.1. North America Digital Therapeutics Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
4.1.1. Key Highlights
4.1.1.1. Diabetes
4.1.1.2. Obesity
4.1.1.3. CVD
4.1.1.4. Smoking Cessation
4.1.1.5. CNS Diseases
4.1.1.6. Others
4.2. North America Digital Therapeutics Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
4.2.1. Key Highlights
4.2.1.1. Patients
4.2.1.2. Providers
4.2.1.3. Payers
4.2.1.4. Employers
4.2.1.5. Other End users
4.2.2. BPS Analysis/Market Attractiveness Analysis
4.3. North America Digital Therapeutics Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
4.3.1. Key Highlights
4.3.1.1. U.S. Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
4.3.1.2. U.S. Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
4.3.1.3. Canada Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
4.3.1.4. Canada Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Digital Therapeutics Market Outlook, 2018 - 2030
5.1. Europe Digital Therapeutics Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
5.1.1. Key Highlights
5.1.1.1. Diabetes
5.1.1.2. Obesity
5.1.1.3. CVD
5.1.1.4. Smoking Cessation
5.1.1.5. CNS Diseases
5.1.1.6. Others
5.2. Europe Digital Therapeutics Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
5.2.1. Key Highlights
5.2.1.1. Patients
5.2.1.2. Providers
5.2.1.3. Payers
5.2.1.4. Employers
5.2.1.5. Other End users
5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe Digital Therapeutics Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
5.3.1. Key Highlights
5.3.1.1. Germany Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
5.3.1.2. Germany Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
5.3.1.3. U.K. Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
5.3.1.4. U.K. Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
5.3.1.5. France Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
5.3.1.6. France Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
5.3.1.7. Italy Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
5.3.1.8. Italy Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
5.3.1.9. Turkey Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
5.3.1.10. Turkey Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
5.3.1.11. Russia Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
5.3.1.12. Russia Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
5.3.1.13. Rest of Europe Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
5.3.1.14. Rest of Europe Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Digital Therapeutics Market Outlook, 2018 - 2030
6.1. Asia Pacific Digital Therapeutics Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
6.1.1. Key Highlights
6.1.1.1. Diabetes
6.1.1.2. Obesity
6.1.1.3. CVD
6.1.1.4. Smoking Cessation
6.1.1.5. CNS Diseases
6.1.1.6. Others
6.2. Asia Pacific Digital Therapeutics Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
6.2.1. Key Highlights
6.2.1.1. Patients
6.2.1.2. Providers
6.2.1.3. Payers
6.2.1.4. Employers
6.2.1.5. Other End users
6.2.2. BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Digital Therapeutics Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
6.3.1. Key Highlights
6.3.1.1. China Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
6.3.1.2. China Digital Therapeutics Market by End User, Value (US$ Bn), 2018 - 2030
6.3.1.3. Japan Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
6.3.1.4. Japan Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
6.3.1.5. South Korea Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
6.3.1.6. South Korea Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
6.3.1.7. India Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
6.3.1.8. India Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
6.3.1.9. Southeast Asia Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
6.3.1.10. Southeast Asia Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
6.3.1.11. Rest of Asia Pacific Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
6.3.1.12. Rest of Asia Pacific Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Digital Therapeutics Market Outlook, 2018 - 2030
7.1. Latin America Digital Therapeutics Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
7.1.1. Key Highlights
7.1.1.1. Diabetes
7.1.1.2. Obesity
7.1.1.3. CVD
7.1.1.4. Smoking Cessation
7.1.1.5. CNS Diseases
7.1.1.6. Others
7.2. Latin America Digital Therapeutics Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
7.2.1. Key Highlights
7.2.1.1. Patients
7.2.1.2. Providers
7.2.1.3. Payers
7.2.1.4. Employers
7.2.1.5. Other End users
7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Digital Therapeutics Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
7.3.1. Key Highlights
7.3.1.1. Brazil Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
7.3.1.2. Brazil Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
7.3.1.3. Mexico Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
7.3.1.4. Mexico Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
7.3.1.5. Argentina Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
7.3.1.6. Argentina Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
7.3.1.7. Rest of Latin America Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
7.3.1.8. Rest of Latin America Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Digital Therapeutics Market Outlook, 2018 - 2030
8.1. Middle East & Africa Digital Therapeutics Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
8.1.1. Key Highlights
8.1.1.1. Diabetes
8.1.1.2. Obesity
8.1.1.3. CVD
8.1.1.4. Smoking Cessation
8.1.1.5. CNS Diseases
8.1.1.6. Others
8.2. Middle East & Africa Digital Therapeutics Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
8.2.1. Key Highlights
8.2.1.1. Patients
8.2.1.2. Providers
8.2.1.3. Payers
8.2.1.4. Employers
8.2.1.5. Other End users
8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa Digital Therapeutics Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
8.3.1. Key Highlights
8.3.1.1. GCC Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
8.3.1.2. GCC Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
8.3.1.3. South Africa Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
8.3.1.4. South Africa Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
8.3.1.5. Egypt Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
8.3.1.6. Egypt Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
8.3.1.7. Nigeria Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
8.3.1.8. Nigeria Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
8.3.1.9. Rest of Middle East & Africa Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
8.3.1.10. Rest of Middle East & Africa Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Manufacturer vs End User Heatmap
9.2. Company Market Share Analysis, 2022
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Pear Therapeutics
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Akili Interactive Labs
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Click Therapeutics
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Omada Health
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. WellDoc
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Propeller Health
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. 2Morrow
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Hinge Health
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Canary Health
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Better Therapeutics
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
9.4.11. Kaia Health
9.4.11.1. Company Overview
9.4.11.2. Product Portfolio
9.4.11.3. Financial Overview
9.4.11.4. Business Strategies and Development
9.4.12. DarioHealth
9.4.12.1. Company Overview
9.4.12.2. Product Portfolio
9.4.12.3. Financial Overview
9.4.12.4. Business Strategies and Development
9.4.13. Mindstrong Health
9.4.13.1. Company Overview
9.4.13.2. Product Portfolio
9.4.13.3. Financial Overview
9.4.13.4. Business Strategies and Development
9.4.14. Biofourmis
9.4.14.1. Company Overview
9.4.14.2. Product Portfolio
9.4.14.3. Financial Overview
9.4.14.4. Business Strategies and Development
9.4.15. Ginger
9.4.15.1. Company Overview
9.4.15.2. Product Portfolio
9.4.15.3. Financial Overview
9.4.15.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations